Over this past weekend, The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend Moderna COVID-19 vaccine for children ages 6 months through 5 years and Pfizer-BioNTech vaccine for children ages 6 months through 4 years. This is great news for those who care for infants and children.
Given that we have waited some time for the vaccine availability, many wonder about natural immunity versus vaccine immunity response. The data shows that among children, COVID-19 vaccine produces a better immune response when compared with children who develop natural immunity from SARS-CoV-2 infection. Those vaccinated with two doses of COVID-19 vaccine show higher titers (protection) against alpha, beta, gamma, delta and omicron variants.
We have learned much throughout the COVID-19 pandemic. The role of vaccination remains the same, to reduce preventable infectious disease and especially severe disease. As always, it is important we continue to have real-life data and continue to encourage everyone to sign up for V-Safe, the CDC’s vaccine reporting system.
Pediatric and general practice clinics that care for children will be the mainstay in providing vaccines for younger children. After safely vaccinating millions of children and adolescents, we now have a chance to offer vaccines to families with younger infants and children. HSC Health expects to receive its initial shipment of pediatric vaccine in the coming week. For more information about scheduling your child’s vaccine appointment call 817-735-2363.